The human CD45% was significantly higher in spleen, bone marrow, and peripheral blood of pCAR-Y05(1XX)/F CAR T-cell treated mice, although differences in liver did not reach statistical significance ( Fig. 6a ).
← all excerpts
Optimization of a parallel CAR for B-cell lymphoma via ITAM attenuation and target specificity validation.
1
—
—